Chemotherapy-Induced Nausea and Vomiting (CINV)
14 clinical trials · Condition
◉ Watch Chemotherapy-Induced Nausea and Vomiting (CINV)
| Record | Firm | Date |
|---|---|---|
| Safety Study of Repeat Doses of SUSTOL in Adults (NCT05434663) | Heron Therapeutics | 2022-07-06 |
| Granisetron Transdermal Patch for Prophylaxis of Delayed CINV (NCT04912271) | Fudan University | 2021-06-10 |
| PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting (NCT03204279) | Helsinn Healthcare SA | 2017-08-31 |
| Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) (NCT01594749) | Merck Sharp & Dohme LLC | 2012-09-24 |
| Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) (NCT01111851) | Merck Sharp & Dohme LLC | 2010-04-01 |
| Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) (NCT00952341) | Merck Sharp & Dohme LLC | 2009-08-25 |
| Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) (NCT00619359) | Merck Sharp & Dohme LLC | 2008-02-01 |
Track Chemotherapy-Induced Nausea and Vomiting (CINV) automatically
Every clearance here is in the API, with alerts when new ones post.